| Tyrone Springs, | |
|
252 County Road 601, Belle Mead, NJ 08502-3923 | |
| (908) 281-1000 | |
| Not Available |
| Full Name | Tyrone Springs |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 252 County Road 601, Belle Mead, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184282410 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | 26NJ00931800 (New Jersey) | Primary |
| Entity Name | Garden State Healthcare Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700014545 PECOS PAC ID: 8426190687 Enrollment ID: O20100126000693 |
News Archive
In a continuing effort to serve the health care needs of medically underserved populations across Birmingham and the state of Alabama, the University of Alabama at Birmingham School of Nursing has long partnered with community agencies and facilities to identify and assist those who struggle most to receive proper health care by providing care through the school's nurse-managed clinics.
Researchers at the Buck Institute for Age Research have successfully used human induced pluripotent stem cells (iPSCs) to treat rodents afflicted with Parkinson's Disease (PD). The research, which validates a scalable protocol that the same group had previously developed, can be used to manufacture the type of neurons needed to treat the disease and paves the way for the use of iPSC's in various biomedical applications. Results of the research, from the laboratory of Buck faculty Xianmin Zeng, Ph.D., are published August 16, 2010 in the on-line edition of the journal Stem Cells.
Affymax, Inc. and Takeda Global Research & Development Center, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced preliminary top-line results from the Phase 3 clinical program for the investigational drug, Hematide™/peginesatide, for the treatment of anemia in chronic renal failure patients.
Researchers explore individuals' confidence or reluctance to vaccinate their families and the associated effects on global health, in a collection published on February 25, 2015 by the open-access journal, PLOS Currents: Outbreaks. The collection is accompanied by the editorial "Hesitancy, trust and individualism in vaccination decision-making" by Jonathan E. Suk et al. from the European Centre for Disease Prevention and Control.
Hypoxia is a key factor that accompanies most brain pathologies, including ischemia and neurodegenerative diseases.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tyrone Springs, Po Box 981, Old Bridge, NJ 08857-0981 Ph: (732) 319-4606 | Tyrone Springs, 252 County Road 601, Belle Mead, NJ 08502-3923 Ph: (908) 281-1000 |
News Archive
In a continuing effort to serve the health care needs of medically underserved populations across Birmingham and the state of Alabama, the University of Alabama at Birmingham School of Nursing has long partnered with community agencies and facilities to identify and assist those who struggle most to receive proper health care by providing care through the school's nurse-managed clinics.
Researchers at the Buck Institute for Age Research have successfully used human induced pluripotent stem cells (iPSCs) to treat rodents afflicted with Parkinson's Disease (PD). The research, which validates a scalable protocol that the same group had previously developed, can be used to manufacture the type of neurons needed to treat the disease and paves the way for the use of iPSC's in various biomedical applications. Results of the research, from the laboratory of Buck faculty Xianmin Zeng, Ph.D., are published August 16, 2010 in the on-line edition of the journal Stem Cells.
Affymax, Inc. and Takeda Global Research & Development Center, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced preliminary top-line results from the Phase 3 clinical program for the investigational drug, Hematide™/peginesatide, for the treatment of anemia in chronic renal failure patients.
Researchers explore individuals' confidence or reluctance to vaccinate their families and the associated effects on global health, in a collection published on February 25, 2015 by the open-access journal, PLOS Currents: Outbreaks. The collection is accompanied by the editorial "Hesitancy, trust and individualism in vaccination decision-making" by Jonathan E. Suk et al. from the European Centre for Disease Prevention and Control.
Hypoxia is a key factor that accompanies most brain pathologies, including ischemia and neurodegenerative diseases.
› Verified 9 days ago
Zaid Sika Iddrisu, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 252 County Road 601, Belle Mead, NJ 08502 Phone: 646-406-6497 | |
Miss Fawcett Siew Suit Lee, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 9 Dutchtown Harlingen Rd, Belle Mead, NJ 08502 Phone: 908-874-8883 Fax: 908-874-3595 | |
Dawn Amber Straiton, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 252 County Road 601, Belle Mead, NJ 08502 Phone: 908-281-1000 | |
Laura Marie Endrizzi, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 252 County Road 601, Belle Mead, NJ 08502 Phone: 908-281-1000 | |
Nancy Theresa Spalluto, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 252 County Road 601, Belle Mead, NJ 08502 Phone: 908-281-1000 | |
Ruth Mugo, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 252 County Road 601, Belle Mead, NJ 08502 Phone: 908-281-1000 |